Viewing Study NCT01231659

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:28 PM
Ignite Modification Date: 2026-01-28 @ 6:56 PM
Study NCT ID: NCT01231659
Status: COMPLETED
Last Update Posted: 2021-03-26
First Post: 2010-10-28
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Safety and Efficacy of RAD001 (Everolimus) in Combination With Letrozole in the Treatment of Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Postmenopausal Women View
None Locally Advanced Metastatic Breast Cancer View
None Metastatic Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None RAD001 (Everolimus) View
None Letrozole View
None Breast cancer View
None Metastatic Breast cancer View
None Estrogen receptor positive View
None Failure of Tamoxifen View
None Anastrozole or Examestane View